Skip to main content
. 2020 Mar 27;323(16):1582–1589. doi: 10.1001/jama.2020.4783

Table 3. Characteristics and Antibody Titer of Convalescent Plasma Donors.

Donorsa
1 2 3 4 5
Blood type B B B A B
Donated plasma volume, mL 400 400 400 400 400
Interval between symptom onset and discharge, d 11 11 13 13 11
Interval between discharge and plasma donation, d 11 11 13 11 12
RBD-specific IgG ELISA titerb 16 200 1800 1800 5400 16 200
RBD-specific IgM ELISA titerc 16 200 1800 5400 5400 5400
Neutralizing antibody titerd 240 80 120 240 480

Abbreviation: RBD, receptor binding domain.

a

Donors-patients were matched by number (donor 1 gave plasma to patient 1, etc).

b

ELISA end point dilution titers (IgG antibody). The expected titer of negative control from a healthy person is ≤200.

c

ELISA end point dilution titers (IgM antibody). The expected titer of negative control from a healthy person is ≤200.

d

Neutralization end point dilution titers. The expected titer of negative control from a healthy person is ≤10.